IperionX’s (IPX) “Buy” Rating Reaffirmed at Roth Capital

Roth Capital reaffirmed their buy rating on shares of IperionX (NASDAQ:IPX) in a report published on Tuesday,Benzinga reports. They currently have a $74.00 target price on the stock.

A number of other equities analysts also recently commented on the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of IperionX in a research report on Wednesday, October 8th. William Blair began coverage on IperionX in a report on Tuesday, January 13th. They set an “outperform” rating on the stock. Finally, Wall Street Zen lowered shares of IperionX from a “hold” rating to a “sell” rating in a report on Friday, October 3rd. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $51.00.

IperionX Trading Up 2.7%

IPX stock opened at $48.07 on Tuesday. The company has a current ratio of 6.99, a quick ratio of 6.99 and a debt-to-equity ratio of 0.04. The firm has a 50-day moving average of $36.75 and a two-hundred day moving average of $41.11. IperionX has a 12 month low of $12.27 and a 12 month high of $60.90.

Hedge Funds Weigh In On IperionX

Large investors have recently made changes to their positions in the stock. Jones Financial Companies Lllp purchased a new position in shares of IperionX during the 3rd quarter worth approximately $36,000. GAMMA Investing LLC lifted its stake in IperionX by 684.4% during the second quarter. GAMMA Investing LLC now owns 957 shares of the company’s stock worth $30,000 after purchasing an additional 835 shares in the last quarter. Cape Investment Advisory Inc. purchased a new position in shares of IperionX during the second quarter worth $34,000. JPMorgan Chase & Co. purchased a new position in shares of IperionX during the second quarter worth $66,000. Finally, Vanguard Personalized Indexing Management LLC acquired a new stake in shares of IperionX in the third quarter valued at $297,000. 2.76% of the stock is currently owned by institutional investors and hedge funds.

About IperionX

IperionX (NASDAQ: IPX) is a mineral technology company focused on the production and commercialization of high‐purity titanium and zirconium products. The company’s core activities include the development of advanced mineral sands projects and the deployment of proprietary processing technologies aimed at supplying feedstocks to aerospace, defense, additive manufacturing and battery markets.

At the heart of IperionX’s operations is the Stony Creek Project in Virginia, where the company holds significant mineral sands rights.